GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VIRI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Virios Therapeutics, LLC stock price after Wednesday trading.
(Updated on Apr 17, 2024)

Hold candidate since Apr 17, 2024 PDF

The Virios Therapeutics, LLC stock price fell by -0.243% on the last day (Wednesday, 17th Apr 2024) from $0.452 to $0.451. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 6.64% from a day low at $0.450 to a day high of $0.480. The price has fallen in 6 of the last 10 days and is down by -8.35% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -78 thousand shares and in total, 86 thousand shares were bought and sold for approximately $38.73 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Virios Therapeutics, LLC stock with a 90% probability to be traded between $0.307 and $0.573 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VIRI Signals & Forecast

The Virios Therapeutics, LLC stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.471. On a fall, the stock will find some support from the long-term average at approximately $0.414. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -22.26%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Virios Therapeutics, LLC stock

Virios Therapeutics, LLC finds support from accumulated volume at $0.430 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0299 between high and low, or 6.64%. For the last week the stock has had daily average volatility of 11.40%.

Our recommended stop-loss: $0.423 (-6.10%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 12 days ago.)

Trading Expectations (VIRI) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Virios Therapeutics, LLC to open at $0.460, and during the day (based on 14 day Average True Range), to move between $0.385 and $0.517, which gives a possible trading interval of +/-$0.0657 (+/-14.58%) up or down from last closing price. If Virios Therapeutics, LLC takes out the full calculated possible swing range there will be an estimated 29.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.457 (1.44%) than the support at $0.430 (4.61%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Virios Therapeutics, LLC stock A Buy?

Virios Therapeutics, LLC holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.769 Hold/Accumulate Upgraded

Predicted Opening Price for Virios Therapeutics, LLC of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$0.460 ( 2.08%) $0.451

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VIRI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.490 8.71 %
R2 0.479 6.18 %
R1 0.472 4.61 %
Current price: 0.451
Support S1 0.449 -0.456 %
S2 0.442 -2.02 %
S3 0.430 -4.55 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.484 7.43 %
R2 0.470 4.19 %
R1 0.457 1.44 %
Current price 0.451
Support S1 0.430 -4.61%
S2 0.423 -6.30%
S3 0.387 -14.15%

FAQ

What is the symbol for Virios Therapeutics, LLC Stock and on which exchange is it traded?
The symbol for Virios Therapeutics, LLC is VIRI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Virios Therapeutics, LLC Stock?
Virios Therapeutics, LLC holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Virios Therapeutics, LLC Stock?
Virios Therapeutics, LLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Virios Therapeutics, LLC Stock.

What's the current price of Virios Therapeutics, LLC Stock?
As of the end of day on the 2024-04-17, the price of an Virios Therapeutics, LLC (VIRI) share was $0.451.

What is the 52-week high and low for Virios Therapeutics, LLC Stock?
The 52-week high for Virios Therapeutics, LLC Stock is $2.42 and the 52-week low is $0.280.

What is the market capitalization of Virios Therapeutics, LLC Stock?
As of the 2024-04-17, the market capitalization of Virios Therapeutics, LLC is 8.683M.

When is the next earnings date for Virios Therapeutics, LLC?
The upcoming earnings date for Virios Therapeutics, LLC is May 09, 2024.
Click to get the best stock tips daily for free!

About Virios Therapeutics, LLC

Virios Therapeutics LLC Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, atten... VIRI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT